HealthUS regulator orders weight-loss drugs to add vision-loss warning
The FDA is requiring manufacturers of GLP-1 medicines to update safety labels to warn that the risk of a rare but serious eye condition may be increased. The condition can cause permanent vision loss.
US regulator orders weight-loss drugs to add vision-loss warning